 | • レポートコード：QAF27547 • 出版社/出版日：QYResearch / 2021年4月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、148ページ • 納品方法：Eメール（即日納品） • 産業分類：医薬品 |
| Single User | ￥592,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥888,000 (USD6,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本市場調査資料では、世界のアルブミン（賦形剤）市場について種類別（ヒト血清アルブミン、組換えアルブミン）、用途別（細胞培養培地、医療サプリメント、治療薬）、地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2016年～2027年までの市場規模と予測（販売量、売上、価格）、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・アルブミン（賦形剤）市場の概要 ・世界の主要地域別アルブミン（賦形剤）市場規模2016-2027 ・主要プレイヤーの競争状況・市場シェア ・世界のアルブミン（賦形剤）市場規模2016-2021：種類別（ヒト血清アルブミン、組換えアルブミン） ・世界のアルブミン（賦形剤）市場予測2012-2027：種類別（ヒト血清アルブミン、組換えアルブミン） ・世界のアルブミン（賦形剤）市場規模2016-2021：用途別（細胞培養培地、医療サプリメント、治療薬） ・世界のアルブミン（賦形剤）市場予測2012-2027：用途別（細胞培養培地、医療サプリメント、治療薬） ・アルブミン（賦形剤）のアメリカ市場規模と予測2016-2021 ・アルブミン（賦形剤）のヨーロッパ市場規模と予測2016-2021 ・アルブミン（賦形剤）の中国市場規模と予測2016-2021 ・アルブミン（賦形剤）の日本市場規模と予測2016-2021 ・アルブミン（賦形剤）の東南アジア市場規模と予測2016-2021 ・アルブミン（賦形剤）のインド市場規模と予測2016-2021 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 （CSL、Grifols、Takeda、Octapharma、Hualan Bio、CBPO、Shanghai RAAS、Kedrion、LFB Group、Albumedix、Biotest、Merck、Ventria (InVitria)、HiMedia） ・アルブミン（賦形剤）の製造コスト分析 ・販売チャネル、流通業者、顧客 ・アルブミン（賦形剤）の市場動向・機会・課題 ・調査の結論 |
Albumin is a water-soluble globular protein produced in the liver. It accounts for 50% of blood plasma proteins. These play a vital role in regulating blood volume and act as transporters for molecules such as few hormones, bile salts, and ions. Albumin is commonly used as blood volumizer in rare diseases, burns, shocks, liver conditions, and other blood loss trauma and surgeries.
The industry’s leading manufacturers are Grifols, CSL and Takeda, which accounted for 20.39%, 15.19% and 14.36% of global revenues in 2019.
By region, Asia-Pacific is the largest consumption market of Albumin (as Excipient), with its sales volume at 70.83%.
Market Analysis and Insights: Global Albumin (as Excipient) Market
The global Albumin (as Excipient) market was valued at US$ 4340.4 in 2020 and will reach US$ 6191.9 million by the end of 2027, growing at a CAGR of 6.1% during 2022-2027.
Global Albumin (as Excipient) Scope and Market Size
The global Albumin (as Excipient) market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Albumin (as Excipient) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.
Segment by Type
Human Serum Albumin
Recombinant Albumin
In terms of type, Human Serum Albumin has the highest proportion of revenue, exceeding 98% in 2019.
Segment by Application
Cell Culture Media
Medical Supplements
Therapeutics
Therapeutics had the highest share of sales by application, at 73.27% in 2019.
The Albumin (as Excipient) market is analysed and market size information is provided by regions (countries). Segment by Application, the Albumin (as Excipient) market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.
By Company
CSL
Grifols
Takeda
Octapharma
Hualan Bio
CBPO
Shanghai RAAS
Kedrion
LFB Group
Albumedix
Biotest
Merck
Ventria (InVitria)
HiMedia
1 Albumin (as Excipient) Market Overview
1.1 Albumin (as Excipient) Product Scope
1.2 Albumin (as Excipient) Segment by Type
1.2.1 Global Albumin (as Excipient) Sales by Type (2016 & 2021 & 2027)
1.2.2 Human Serum Albumin
1.2.3 Recombinant Albumin
1.3 Albumin (as Excipient) Segment by Application
1.3.1 Global Albumin (as Excipient) Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Cell Culture Media
1.3.3 Medical Supplements
1.3.4 Therapeutics
1.4 Albumin (as Excipient) Market Estimates and Forecasts (2016-2027)
1.4.1 Global Albumin (as Excipient) Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Albumin (as Excipient) Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Albumin (as Excipient) Price Trends (2016-2027)
2 Albumin (as Excipient) Estimates and Forecasts by Region
2.1 Global Albumin (as Excipient) Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Albumin (as Excipient) Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Albumin (as Excipient) Sales Market Share by Region (2016-2021)
2.2.2 Global Albumin (as Excipient) Revenue Market Share by Region (2016-2021)
2.3 Global Albumin (as Excipient) Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Albumin (as Excipient) Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Albumin (as Excipient) Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Albumin (as Excipient) Estimates and Projections (2016-2027)
2.4.2 Europe Albumin (as Excipient) Estimates and Projections (2016-2027)
2.4.3 China Albumin (as Excipient) Estimates and Projections (2016-2027)
2.4.4 Japan Albumin (as Excipient) Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Albumin (as Excipient) Estimates and Projections (2016-2027)
2.4.6 India Albumin (as Excipient) Estimates and Projections (2016-2027)
3 Global Albumin (as Excipient) Competition Landscape by Players
3.1 Global Top Albumin (as Excipient) Players by Sales (2016-2021)
3.2 Global Top Albumin (as Excipient) Players by Revenue (2016-2021)
3.3 Global Albumin (as Excipient) Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Albumin (as Excipient) as of 2020)
3.4 Global Albumin (as Excipient) Average Price by Company (2016-2021)
3.5 Manufacturers Albumin (as Excipient) Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Albumin (as Excipient) Market Size by Type
4.1 Global Albumin (as Excipient) Historic Market Review by Type (2016-2021)
4.1.1 Global Albumin (as Excipient) Sales Market Share by Type (2016-2021)
4.1.2 Global Albumin (as Excipient) Revenue Market Share by Type (2016-2021)
4.1.3 Global Albumin (as Excipient) Price by Type (2016-2021)
4.2 Global Albumin (as Excipient) Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Albumin (as Excipient) Sales Forecast by Type (2022-2027)
4.2.2 Global Albumin (as Excipient) Revenue Forecast by Type (2022-2027)
4.2.3 Global Albumin (as Excipient) Price Forecast by Type (2022-2027)
5 Global Albumin (as Excipient) Market Size by Application
5.1 Global Albumin (as Excipient) Historic Market Review by Application (2016-2021)
5.1.1 Global Albumin (as Excipient) Sales Market Share by Application (2016-2021)
5.1.2 Global Albumin (as Excipient) Revenue Market Share by Application (2016-2021)
5.1.3 Global Albumin (as Excipient) Price by Application (2016-2021)
5.2 Global Albumin (as Excipient) Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Albumin (as Excipient) Sales Forecast by Application (2022-2027)
5.2.2 Global Albumin (as Excipient) Revenue Forecast by Application (2022-2027)
5.2.3 Global Albumin (as Excipient) Price Forecast by Application (2022-2027)
6 North America Albumin (as Excipient) Market Facts & Figures
6.1 North America Albumin (as Excipient) Sales by Company
6.1.1 North America Albumin (as Excipient) Sales by Company (2016-2021)
6.1.2 North America Albumin (as Excipient) Revenue by Company (2016-2021)
6.2 North America Albumin (as Excipient) Sales Breakdown by Type
6.2.1 North America Albumin (as Excipient) Sales Breakdown by Type (2016-2021)
6.2.2 North America Albumin (as Excipient) Sales Breakdown by Type (2022-2027)
6.3 North America Albumin (as Excipient) Sales Breakdown by Application
6.3.1 North America Albumin (as Excipient) Sales Breakdown by Application (2016-2021)
6.3.2 North America Albumin (as Excipient) Sales Breakdown by Application (2022-2027)
7 Europe Albumin (as Excipient) Market Facts & Figures
7.1 Europe Albumin (as Excipient) Sales by Company
7.1.1 Europe Albumin (as Excipient) Sales by Company (2016-2021)
7.1.2 Europe Albumin (as Excipient) Revenue by Company (2016-2021)
7.2 Europe Albumin (as Excipient) Sales Breakdown by Type
7.2.1 Europe Albumin (as Excipient) Sales Breakdown by Type (2016-2021)
7.2.2 Europe Albumin (as Excipient) Sales Breakdown by Type (2022-2027)
7.3 Europe Albumin (as Excipient) Sales Breakdown by Application
7.3.1 Europe 148 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 148 Sales Breakdown by Application (2022-2027)
8 China Albumin (as Excipient) Market Facts & Figures
8.1 China Albumin (as Excipient) Sales by Company
8.1.1 China Albumin (as Excipient) Sales by Company (2016-2021)
8.1.2 China Albumin (as Excipient) Revenue by Company (2016-2021)
8.2 China Albumin (as Excipient) Sales Breakdown by Type
8.2.1 China Albumin (as Excipient) Sales Breakdown by Type (2016-2021)
8.2.2 China Albumin (as Excipient) Sales Breakdown by Type (2022-2027)
8.3 China Albumin (as Excipient) Sales Breakdown by Application
8.3.1 China 316 Sales Breakdown by Application (2016-2021)
8.3.2 China 316 Sales Breakdown by Application (2022-2027)
9 Japan Albumin (as Excipient) Market Facts & Figures
9.1 Japan Albumin (as Excipient) Sales by Company
9.1.1 Japan Albumin (as Excipient) Sales by Company (2016-2021)
9.1.2 Japan Albumin (as Excipient) Revenue by Company (2016-2021)
9.2 Japan Albumin (as Excipient) Sales Breakdown by Type
9.2.1 Japan Albumin (as Excipient) Sales Breakdown by Type (2016-2021)
9.2.2 Japan Albumin (as Excipient) Sales Breakdown by Type (2022-2027)
9.3 Japan Albumin (as Excipient) Sales Breakdown by Application
9.3.1 Japan Jan. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Jan. Sales Breakdown by Application (2022-2027)
10 Southeast Asia Albumin (as Excipient) Market Facts & Figures
10.1 Southeast Asia Albumin (as Excipient) Sales by Company
10.1.1 Southeast Asia Albumin (as Excipient) Sales by Company (2016-2021)
10.1.2 Southeast Asia Albumin (as Excipient) Revenue by Company (2016-2021)
10.2 Southeast Asia Albumin (as Excipient) Sales Breakdown by Type
10.2.1 Southeast Asia Albumin (as Excipient) Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Albumin (as Excipient) Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Albumin (as Excipient) Sales Breakdown by Application
10.3.1 Southeast Asia MT Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia MT Sales Breakdown by Application (2022-2027)
11 India Albumin (as Excipient) Market Facts & Figures
11.1 India Albumin (as Excipient) Sales by Company
11.1.1 India Albumin (as Excipient) Sales by Company (2016-2021)
11.1.2 India Albumin (as Excipient) Revenue by Company (2016-2021)
11.2 India Albumin (as Excipient) Sales Breakdown by Type
11.2.1 India Albumin (as Excipient) Sales Breakdown by Type (2016-2021)
11.2.2 India Albumin (as Excipient) Sales Breakdown by Type (2022-2027)
11.3 India Albumin (as Excipient) Sales Breakdown by Application
11.3.1 India Albumin (as Excipient) Sales Breakdown by Application (2016-2021)
11.3.2 India Albumin (as Excipient) Sales Breakdown by Application (2022-2027)
12 Company Profiles and Key Figures in Albumin (as Excipient) Business
12.1 CSL
12.1.1 CSL Corporation Information
12.1.2 CSL Business Overview
12.1.3 CSL Albumin (as Excipient) Sales, Revenue and Gross Margin (2016-2021)
12.1.4 CSL Albumin (as Excipient) Products Offered
12.1.5 CSL Recent Development
12.2 Grifols
12.2.1 Grifols Corporation Information
12.2.2 Grifols Business Overview
12.2.3 Grifols Albumin (as Excipient) Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Grifols Albumin (as Excipient) Products Offered
12.2.5 Grifols Recent Development
12.3 Takeda
12.3.1 Takeda Corporation Information
12.3.2 Takeda Business Overview
12.3.3 Takeda Albumin (as Excipient) Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Takeda Albumin (as Excipient) Products Offered
12.3.5 Takeda Recent Development
12.4 Octapharma
12.4.1 Octapharma Corporation Information
12.4.2 Octapharma Business Overview
12.4.3 Octapharma Albumin (as Excipient) Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Octapharma Albumin (as Excipient) Products Offered
12.4.5 Octapharma Recent Development
12.5 Hualan Bio
12.5.1 Hualan Bio Corporation Information
12.5.2 Hualan Bio Business Overview
12.5.3 Hualan Bio Albumin (as Excipient) Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Hualan Bio Albumin (as Excipient) Products Offered
12.5.5 Hualan Bio Recent Development
12.6 CBPO
12.6.1 CBPO Corporation Information
12.6.2 CBPO Business Overview
12.6.3 CBPO Albumin (as Excipient) Sales, Revenue and Gross Margin (2016-2021)
12.6.4 CBPO Albumin (as Excipient) Products Offered
12.6.5 CBPO Recent Development
12.7 Shanghai RAAS
12.7.1 Shanghai RAAS Corporation Information
12.7.2 Shanghai RAAS Business Overview
12.7.3 Shanghai RAAS Albumin (as Excipient) Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Shanghai RAAS Albumin (as Excipient) Products Offered
12.7.5 Shanghai RAAS Recent Development
12.8 Kedrion
12.8.1 Kedrion Corporation Information
12.8.2 Kedrion Business Overview
12.8.3 Kedrion Albumin (as Excipient) Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Kedrion Albumin (as Excipient) Products Offered
12.8.5 Kedrion Recent Development
12.9 LFB Group
12.9.1 LFB Group Corporation Information
12.9.2 LFB Group Business Overview
12.9.3 LFB Group Albumin (as Excipient) Sales, Revenue and Gross Margin (2016-2021)
12.9.4 LFB Group Albumin (as Excipient) Products Offered
12.9.5 LFB Group Recent Development
12.10 Albumedix
12.10.1 Albumedix Corporation Information
12.10.2 Albumedix Business Overview
12.10.3 Albumedix Albumin (as Excipient) Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Albumedix Albumin (as Excipient) Products Offered
12.10.5 Albumedix Recent Development
12.11 Biotest
12.11.1 Biotest Corporation Information
12.11.2 Biotest Business Overview
12.11.3 Biotest Albumin (as Excipient) Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Biotest Albumin (as Excipient) Products Offered
12.11.5 Biotest Recent Development
12.12 Merck
12.12.1 Merck Corporation Information
12.12.2 Merck Business Overview
12.12.3 Merck Albumin (as Excipient) Sales, Revenue and Gross Margin (2016-2021)
12.12.4 Merck Albumin (as Excipient) Products Offered
12.12.5 Merck Recent Development
12.13 Ventria (InVitria)
12.13.1 Ventria (InVitria) Corporation Information
12.13.2 Ventria (InVitria) Business Overview
12.13.3 Ventria (InVitria) Albumin (as Excipient) Sales, Revenue and Gross Margin (2016-2021)
12.13.4 Ventria (InVitria) Albumin (as Excipient) Products Offered
12.13.5 Ventria (InVitria) Recent Development
12.14 HiMedia
12.14.1 HiMedia Corporation Information
12.14.2 HiMedia Business Overview
12.14.3 HiMedia Albumin (as Excipient) Sales, Revenue and Gross Margin (2016-2021)
12.14.4 HiMedia Albumin (as Excipient) Products Offered
12.14.5 HiMedia Recent Development
13 Albumin (as Excipient) Manufacturing Cost Analysis
13.1 Albumin (as Excipient) Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Albumin (as Excipient)
13.4 Albumin (as Excipient) Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Albumin (as Excipient) Distributors List
14.3 Albumin (as Excipient) Customers
15 Market Dynamics
15.1 Albumin (as Excipient) Market Trends
15.2 Albumin (as Excipient) Drivers
15.3 Albumin (as Excipient) Market Challenges
15.4 Albumin (as Excipient) Market Restraints
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Albumin (as Excipient) Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
Table 2. Global Albumin (as Excipient) Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
Table 3. Global Albumin (as Excipient) Market Size (US$ Million) by Region: 2016 VS 2021 &2027
Table 4. Global Albumin (as Excipient) Sales (MT) by Region (2016-2021)
Table 5. Global Albumin (as Excipient) Sales Market Share by Region (2016-2021)
Table 6. Global Albumin (as Excipient) Revenue (US$ Million) Market Share by Region (2016-2021))
Table 7. Global Albumin (as Excipient) Revenue Share by Region (2016-2021)
Table 8. Global Albumin (as Excipient) Sales (MT) Forecast by Region (2022-2027)
Table 9. Global Albumin (as Excipient) Sales Market Share Forecast by Region (2022-2027)
Table 10. Global Albumin (as Excipient) Revenue (US$ Million) Forecast by Region (2022-2027)
Table 11. Global Albumin (as Excipient) Revenue Share Forecast by Region (2022-2027)
Table 12. Global Albumin (as Excipient) Sales (MT) of Key Companies (2016-2021)
Table 13. Global Albumin (as Excipient) Sales Share by Company (2016-2021)
Table 14. Global Albumin (as Excipient) Revenue (US$ Million) by Company (2016-2021)
Table 15. Global Albumin (as Excipient) Revenue Share by Company (2016-2021)
Table 16. Global Albumin (as Excipient) by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Albumin (as Excipient) as of 2020)
Table 17. Global Albumin (as Excipient) Average Price (USD/Kg) of Key Company (2016-2021)
Table 18. Manufacturers Albumin (as Excipient) Manufacturing Sites and Area Served
Table 19. Manufacturers Albumin (as Excipient) Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Global Albumin (as Excipient) Sales (MT) by Type (2016-2021)
Table 22. Global Albumin (as Excipient) Sales Share by Type (2016-2021)
Table 23. Global Albumin (as Excipient) Revenue (US$ Million) Market Share by Type (2016-2021)
Table 24. Global Albumin (as Excipient) Price (USD/Kg) by Type (2016-2021)
Table 25. Global Albumin (as Excipient) Sales Share by Type (2022-2027)
Table 26. Global Albumin (as Excipient) Revenue (US$ Million) Market Share by Type (2022-2027)
Table 27. Global Albumin (as Excipient) Revenue Share by Type (2022-2027)
Table 28. Global Albumin (as Excipient) Price (USD/Kg) by Type (2022-2027)
Table 29. Global Albumin (as Excipient) Sales (MT) by Application (2016-2021)
Table 30. Global Albumin (as Excipient) Sales Share by Application (2016-2021)
Table 31. Global Albumin (as Excipient) Revenue (US$ Million) Market Share by Application (2016-2021)
Table 32. Global Albumin (as Excipient) Price (USD/Kg) by Application (2016-2021)
Table 33. Global Albumin (as Excipient) Sales (MT) by Application (2022-2027)
Table 34. Global Albumin (as Excipient) Sales Share by Application (2022-2027)
Table 35. Global Albumin (as Excipient) Revenue (US$ Million) Market Share by Application (2022-2027)
Table 36. Global Albumin (as Excipient) Revenue Share by Application (2022-2027)
Table 37. Global Albumin (as Excipient) Price (USD/Kg) by Application (2022-2027)
Table 38. North America Albumin (as Excipient) Sales (MT) by Company (2016-2021)
Table 39. North America Albumin (as Excipient) Sales Market Share by Company (2016-2021)
Table 40. North America Albumin (as Excipient) Revenue by Company (2016-2021) & (US$ Million)
Table 41. North America Albumin (as Excipient) Revenue Market Share by Company (2016-2021)
Table 42. North America Albumin (as Excipient) Sales by Type (2016-2021) & (MT)
Table 43. North America Albumin (as Excipient) Sales Market Share by Type (2016-2021)
Table 44. North America Albumin (as Excipient) Sales by Type (2022-2027) & (MT)
Table 45. North America Albumin (as Excipient) Sales Market Share by Type (2022-2027)
Table 46. North America Albumin (as Excipient) Sales by Application (2016-2021) & (MT)
Table 47. North America Albumin (as Excipient) Sales Market Share by Application (2016-2021)
Table 48. North America Albumin (as Excipient) Sales by Application (2022-2027) & (MT)
Table 49. North America Albumin (as Excipient) Sales Market Share by Application (2022-2027)
Table 50. Europe Albumin (as Excipient) Sales (MT) by Company (2016-2021)
Table 51. Europe Albumin (as Excipient) Sales Market Share by Company (2016-2021)
Table 52. Europe Albumin (as Excipient) Revenue by Company (2016-2021) & (US$ Million)
Table 53. Europe Albumin (as Excipient) Revenue Market Share by Company (2016-2021)
Table 54. Europe Albumin (as Excipient) Sales by Type (2016-2021) & (MT)
Table 55. Europe Albumin (as Excipient) Sales Market Share by Type (2016-2021)
Table 56. Europe Albumin (as Excipient) Sales by Type (2022-2027) & (MT)
Table 57. Europe Albumin (as Excipient) Sales Market Share by Type (2022-2027)
Table 58. Europe Albumin (as Excipient) Sales by Application (2016-2021) & (MT)
Table 59. Europe Albumin (as Excipient) Sales Market Share by Application (2016-2021)
Table 60. Europe Albumin (as Excipient) Sales by Application (2022-2027) & (MT)
Table 61. Europe Albumin (as Excipient) Sales Market Share by Application (2022-2027)
Table 62. China Albumin (as Excipient) Sales (MT) by Company (2016-2021)
Table 63. China Albumin (as Excipient) Sales Market Share by Company (2016-2021)
Table 64. China Albumin (as Excipient) Revenue by Company (2016-2021) & (US$ Million)
Table 65. China Albumin (as Excipient) Revenue Market Share by Company (2016-2021)
Table 66. China Albumin (as Excipient) Sales by Type (2016-2021) & (MT)
Table 67. China Albumin (as Excipient) Sales Market Share by Type (2016-2021)
Table 68. China Albumin (as Excipient) Sales by Type (2022-2027) & (MT)
Table 69. China Albumin (as Excipient) Sales Market Share by Type (2022-2027)
Table 70. China Albumin (as Excipient) Sales by Application (2016-2021) & (MT)
Table 71. China Albumin (as Excipient) Sales Market Share by Application (2016-2021)
Table 72. China Albumin (as Excipient) Sales by Application (2022-2027) & (MT)
Table 73. China Albumin (as Excipient) Sales Market Share by Application (2022-2027)
Table 74. Japan Albumin (as Excipient) Sales (MT) by Company (2016-2021)
Table 75. Japan Albumin (as Excipient) Sales Market Share by Company (2016-2021)
Table 76. Japan Albumin (as Excipient) Revenue by Company (2016-2021) & (US$ Million)
Table 77. Japan Albumin (as Excipient) Revenue Market Share by Company (2016-2021)
Table 78. Japan Albumin (as Excipient) Sales by Type (2016-2021) & (MT)
Table 79. Japan Albumin (as Excipient) Sales Market Share by Type (2016-2021)
Table 80. Japan Albumin (as Excipient) Sales by Type (2022-2027) & (MT)
Table 81. Japan Albumin (as Excipient) Sales Market Share by Type (2022-2027)
Table 82. Japan Albumin (as Excipient) Sales by Application (2016-2021) & (MT)
Table 83. Japan Albumin (as Excipient) Sales Market Share by Application (2016-2021)
Table 84. Japan Albumin (as Excipient) Sales by Application (2022-2027) & (MT)
Table 85. Japan Albumin (as Excipient) Sales Market Share by Application (2022-2027)
Table 86. Southeast Asia Albumin (as Excipient) Sales (MT) by Company (2016-2021)
Table 87. Southeast Asia Albumin (as Excipient) Sales Market Share by Company (2016-2021)
Table 88. Southeast Asia Albumin (as Excipient) Revenue by Company (2016-2021) & (US$ Million)
Table 89. Southeast Asia Albumin (as Excipient) Revenue Market Share by Company (2016-2021)
Table 90. Southeast Asia Albumin (as Excipient) Sales by Type (2016-2021) & (MT)
Table 91. Southeast Asia Albumin (as Excipient) Sales Market Share by Type (2016-2021)
Table 92. Southeast Asia Albumin (as Excipient) Sales by Type (2022-2027) & (MT)
Table 93. Southeast Asia Albumin (as Excipient) Sales Market Share by Type (2022-2027)
Table 94. Southeast Asia Albumin (as Excipient) Sales by Application (2016-2021) & (MT)
Table 95. Southeast Asia Albumin (as Excipient) Sales Market Share by Application (2016-2021)
Table 96. Southeast Asia Albumin (as Excipient) Sales by Application (2022-2027) & (MT)
Table 97. Southeast Asia Albumin (as Excipient) Sales Market Share by Application (2022-2027)
Table 98. India Albumin (as Excipient) Sales (MT) by Company (2016-2021)
Table 99. India Albumin (as Excipient) Sales Market Share by Company (2016-2021)
Table 100. India Albumin (as Excipient) Revenue by Company (2016-2021) & (US$ Million)
Table 101. India Albumin (as Excipient) Revenue Market Share by Company (2016-2021)
Table 102. India Albumin (as Excipient) Sales by Type (2016-2021) & (MT)
Table 103. India Albumin (as Excipient) Sales Market Share by Type (2016-2021)
Table 104. India Albumin (as Excipient) Sales by Type (2022-2027) & (MT)
Table 105. India Albumin (as Excipient) Sales Market Share by Type (2022-2027)
Table 106. India Albumin (as Excipient) Sales by Application (2016-2021) & (MT)
Table 107. India Albumin (as Excipient) Sales Market Share by Application (2016-2021)
Table 108. India Albumin (as Excipient) Sales by Application (2022-2027) & (MT)
Table 109. India Albumin (as Excipient) Sales Market Share by Application (2022-2027)
Table 110. CSL Corporation Information
Table 111. CSL Description and Business Overview
Table 112. CSL Albumin (as Excipient) Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2016-2021)
Table 113. CSL Albumin (as Excipient) Product
Table 114. CSL Recent Development
Table 115. Grifols Corporation Information
Table 116. Grifols Description and Business Overview
Table 117. Grifols Albumin (as Excipient) Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2016-2021)
Table 118. Grifols Albumin (as Excipient) Product
Table 119. Grifols Recent Development
Table 120. Takeda Corporation Information
Table 121. Takeda Description and Business Overview
Table 122. Takeda Albumin (as Excipient) Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2016-2021)
Table 123. Takeda Albumin (as Excipient) Product
Table 124. Takeda Recent Development
Table 125. Octapharma Corporation Information
Table 126. Octapharma Description and Business Overview
Table 127. Octapharma Albumin (as Excipient) Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2016-2021)
Table 128. Octapharma Albumin (as Excipient) Product
Table 129. Octapharma Recent Development
Table 130. Hualan Bio Corporation Information
Table 131. Hualan Bio Description and Business Overview
Table 132. Hualan Bio Albumin (as Excipient) Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2016-2021)
Table 133. Hualan Bio Albumin (as Excipient) Product
Table 134. Hualan Bio Recent Development
Table 135. CBPO Corporation Information
Table 136. CBPO Description and Business Overview
Table 137. CBPO Albumin (as Excipient) Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2016-2021)
Table 138. CBPO Albumin (as Excipient) Product
Table 139. CBPO Recent Development
Table 140. Shanghai RAAS Corporation Information
Table 141. Shanghai RAAS Description and Business Overview
Table 142. Shanghai RAAS Albumin (as Excipient) Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2016-2021)
Table 143. Shanghai RAAS Albumin (as Excipient) Product
Table 144. Shanghai RAAS Recent Development
Table 145. Kedrion Corporation Information
Table 146. Kedrion Albumin (as Excipient) Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2016-2021)
Table 147. Kedrion Description and Business Overview
Table 148. Kedrion Albumin (as Excipient) Product
Table 149. Kedrion Recent Development
Table 150. LFB Group Corporation Information
Table 151. LFB Group Albumin (as Excipient) Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2016-2021)
Table 152. LFB Group Description and Business Overview
Table 153. LFB Group Albumin (as Excipient) Product
Table 154. LFB Group Recent Development
Table 155. Albumedix Corporation Information
Table 156. Albumedix Description and Business Overview
Table 157. Albumedix Albumin (as Excipient) Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2016-2021)
Table 158. Albumedix Albumin (as Excipient) Product
Table 159. Albumedix Recent Development
Table 160. Biotest Corporation Information
Table 161. Biotest Description and Business Overview
Table 162. Biotest Albumin (as Excipient) Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2016-2021)
Table 163. Biotest Albumin (as Excipient) Product
Table 164. Biotest Recent Development
Table 165. Merck Corporation Information
Table 166. Merck Description and Business Overview
Table 167. Merck Albumin (as Excipient) Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2016-2021)
Table 168. Merck Albumin (as Excipient) Product
Table 169. Merck Recent Development
Table 170. Ventria (InVitria) Corporation Information
Table 171. Ventria (InVitria) Description and Business Overview
Table 172. Ventria (InVitria) Albumin (as Excipient) Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2016-2021)
Table 173. Ventria (InVitria) Albumin (as Excipient) Product
Table 174. Ventria (InVitria) Recent Development
Table 175. HiMedia Corporation Information
Table 176. HiMedia Description and Business Overview
Table 177. HiMedia Albumin (as Excipient) Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2016-2021)
Table 178. HiMedia Albumin (as Excipient) Product
Table 179. HiMedia Recent Development
Table 180. Production Base and Market Concentration Rate of Raw Material
Table 181. Key Suppliers of Raw Materials
Table 182. Albumin (as Excipient) Distributors List
Table 183. Albumin (as Excipient) Customers List
Table 184. Albumin (as Excipient) Market Trends
Table 185. Albumin (as Excipient) Market Drivers
Table 186. Albumin (as Excipient) Market Challenges
Table 187. Albumin (as Excipient) Market Restraints
Table 188. Research Programs/Design for This Report
Table 189. Key Data Information from Secondary Sources
Table 190. Key Data Information from Primary Sources
List of Figures
Figure 1. Albumin (as Excipient) Product Picture
Figure 2. Global Albumin (as Excipient) Sales Market Share by Type in 2021 & 2027
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Albumin (as Excipient) Sales Market Share by Application in 2021 & 2027
Figure 6. Cell Culture Media Examples
Figure 7. Medical Supplements Examples
Figure 8. Therapeutics Examples
Figure 9. Global Albumin (as Excipient) Sales, (US$ Million), 2016 VS 2021 VS 2027
Figure 10. Global Albumin (as Excipient) Sales Growth Rate (2016-2027) & (US$ Million)
Figure 11. Global Albumin (as Excipient) Sales (MT) Growth Rate (2016-2027)
Figure 12. Global Albumin (as Excipient) Price Trends Growth Rate (2016-2027) (USD/Kg)
Figure 13. Global Albumin (as Excipient) Revenue Market Share by Region: 2016 VS 2021
Figure 14. Global Albumin (as Excipient) Revenue Market Share by Region: 2021 VS 2027
Figure 15. North America Albumin (as Excipient) Revenue (Million USD) Growth Rate (2016-2027)
Figure 16. North America Albumin (as Excipient) Sales (MT) Growth Rate (2016-2027)
Figure 17. Europe Albumin (as Excipient) Revenue (Million USD) Growth Rate (2016-2027)
Figure 18. Europe Albumin (as Excipient) Sales (Million USD) Growth Rate (2016-2027)
Figure 19. China Albumin (as Excipient) Revenue (Million USD) Growth Rate (2016-2027)
Figure 20. China Albumin (as Excipient) Sales (Million USD) and Growth Rate (2016-2027)
Figure 21. Japan Albumin (as Excipient) Revenue (Million USD) Growth Rate (2016-2027)
Figure 22. Japan Albumin (as Excipient) Sales (Million USD) Growth Rate (2016-2027)
Figure 23. Southeast Asia Albumin (as Excipient) Revenue (Million USD) Growth Rate (2016-2027)
Figure 24. Southeast Asia Albumin (as Excipient) Sales (Million USD) Growth Rate (2016-2027)
Figure 25. India Albumin (as Excipient) Revenue (Million USD) Growth Rate (2016-2027)
Figure 26. India Albumin (as Excipient) Sales (Million USD) Growth Rate (2016-2027)
Figure 27. Global 5 Largest Albumin (as Excipient) Players Market Share by Revenue in Albumin (as Excipient): 2016 & 2020
Figure 28. Albumin (as Excipient) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 29. Global Albumin (as Excipient) Revenue Share by Type (2016-2021)
Figure 30. Global Albumin (as Excipient) Revenue Growth Rate by Type in 2016 & 2020
Figure 31. Global Albumin (as Excipient) Revenue Share by Application (2016-2021)
Figure 32. Global Albumin (as Excipient) Revenue Growth Rate by Application in 2016 & 2020
Figure 33. North America Albumin (as Excipient) Sales Market Share by Type in 2020
Figure 34. North America Albumin (as Excipient) Sales Market Share by Application in 2020
Figure 35. Europe Albumin (as Excipient) Sales Market Share by Type in 2020
Figure 36. Europe Albumin (as Excipient) Sales Market Share by Application in 2020
Figure 37. China Albumin (as Excipient) Sales Market Share by Type in 2020
Figure 38. China Albumin (as Excipient) Sales Market Share by Application in 2020
Figure 39. Japan Albumin (as Excipient) Sales Market Share by Type in 2020
Figure 40. Japan Albumin (as Excipient) Sales Market Share by Application in 2020
Figure 41. Southeast Asia Albumin (as Excipient) Sales Market Share by Type in 2020
Figure 42. Southeast Asia Albumin (as Excipient) Sales Market Share by Application in 2020
Figure 43. India Albumin (as Excipient) Sales Market Share by Type in 2020
Figure 44. India Albumin (as Excipient) Sales Market Share by Application in 2020
Figure 45. Key Raw Materials Price Trend
Figure 46. Manufacturing Cost Structure of Albumin (as Excipient)
Figure 47. Manufacturing Process Analysis of Albumin (as Excipient)
Figure 48. Albumin (as Excipient) Industrial Chain Analysis
Figure 49. Channels of Distribution
Figure 50. Distributors Profiles
Figure 51. Bottom-up and Top-down Approaches for This Report
Figure 52. Data Triangulation
Figure 53. Key Executives Interviewed
組換えヒト血清アルブミンのグローバル市場2021 Recombinant Human Serum Albumin (Rec. HSA) is animal origin free expressed in E.coli without animal or human derived raw materials. It is also free from other contaminating serum proteins. Recombinant human serum albumin (rHSA) is genetically engineered and derived from a rice-based expression syste…- 世界の組換えヒト血清アルブミン検査市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Recombinant Human Serum Albumin Test Market The global Recombinant Human Serum Albumin Test market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and h…
- 世界のヒト血清アルブミン検査市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Human Serum Albumin Test Market The global Human Serum Albumin Test market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity, the …
- 世界の血漿由来人血清アルブミン検査市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Plasma-derived Human Serum Albumin Test Market The global Plasma-derived Human Serum Albumin Test market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis…
- ヒト血清アルブミンのグローバル市場調査 2019年 The global Human Serum Albumin market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Human Serum Albumin volume and value at global level, regional level and company level. From a global perspective, this…